MEDIGENE N
MEDIGENE N operates in Diversified Metals & Mining.
Market Cap & Net Worth: MEDIGENE N (MDG1)
MEDIGENE N (BE:MDG1) has a market capitalization of $6.48K (€6.31K) as of March 19, 2026. Listed on the BE stock exchange, this Germany-based company holds position #45638 globally and #7554 in its home market, demonstrating a 5.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEDIGENE N's stock price €0.65 by its total outstanding shares 9679 (9.68K).
MEDIGENE N Market Cap History: 2015 to 2025
MEDIGENE N's market capitalization history from 2015 to 2025. Data shows change from $42.72 to $6.48K (-24.29% CAGR).
MEDIGENE N Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEDIGENE N's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
MEDIGENE N's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $223.33K | $4.89 Million | -$9.49 Million | 0.05x | N/A |
| 2017 | $238.33K | $7.80 Million | -$13.57 Million | 0.03x | N/A |
| 2018 | $139.49K | $7.58 Million | -$17.05 Million | 0.02x | N/A |
| 2019 | $75.83K | $10.51 Million | -$19.96 Million | 0.01x | N/A |
| 2020 | $66.49K | $8.00 Million | -$28.88 Million | 0.01x | N/A |
| 2021 | $52.63K | $10.46 Million | -$9.98 Million | 0.01x | N/A |
| 2022 | $38.67K | $31.25 Million | -$8.33 Million | 0.00x | N/A |
| 2023 | $28.39K | $6.03 Million | -$16.18 Million | 0.00x | N/A |
Competitor Companies of MDG1 by Market Capitalization
Companies near MEDIGENE N in the global market cap rankings as of March 19, 2026.
Key companies related to MEDIGENE N by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2400 globally with a market cap of $6.13 Billion USD ( €5.98 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2412 globally with a market cap of $6.09 Billion USD ( €5.94 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3752 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4657 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2400 | BERKSHIRE HATH-A | BE:BRH | $6.13 Billion | €634500.00 |
| #2412 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.09 Billion | €638000.00 |
| #3752 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4657 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
MEDIGENE N Historical Marketcap From 2015 to 2025
Between 2015 and today, MEDIGENE N's market cap moved from $42.72 to $ 6.48K, with a yearly change of -24.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €6.48K | -37.79% |
| 2024 | €10.41K | -63.32% |
| 2023 | €28.39K | -26.59% |
| 2022 | €38.67K | -26.52% |
| 2021 | €52.63K | -20.85% |
| 2020 | €66.49K | -12.31% |
| 2019 | €75.83K | -45.64% |
| 2018 | €139.49K | -41.47% |
| 2017 | €238.33K | +6.71% |
| 2016 | €223.33K | +522662.79% |
| 2015 | €42.72 | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of MEDIGENE N was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.48K USD |
| MoneyControl | $6.48K USD |
| MarketWatch | $6.48K USD |
| marketcap.company | $6.48K USD |
| Reuters | $6.48K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.